Bio Protocol vs LayerZero — how do they compare? Bio Protocol trades at Rp517 (market cap Rp1,15T, Rp264,79M 24h volume), while LayerZero trades at Rp15,615 (market cap Rp5,48T, Rp261,88M 24h volume). The key difference: LayerZero is far larger — about 4.8× Bio Protocol's market cap, and Bio Protocol's circulating supply is 2,2B / 3,3B BIO (68%) versus 353,7M / 1B ZRO (36%) for LayerZero. Which is the better fit depends on your goals — on Pluang, investors hold Bio Protocol for 16 Days and LayerZero for 13 Days on average.
| BIO | ZRO | |
|---|---|---|
Market Cap | Rp1,15T | Rp5,48T |
Volume (24h) | Rp264,79M | Rp261,88M |
Circulating Supply | 2,2B / 3,3B BIO (68%) | 353,7M / 1B ZRO (36%) |
Typical Hold Time | 16 Days | 13 Days |
Signals from Pluang's Aura AI — not financial advice
Bio Protocol (BIO) trades at Rp514.67 with a market cap of Rp1.15 trillion, showing a bearish technical signal as moving averages indicate selling pressure. The token's circulating supply is 2.2 million out of 3.3 million, with a 68% circulation rate and average hold time of 16 days. Recent news highlights participation in blockchain and tech events, though no major protocol upgrades were reported in the last month.
Overall outlook remains cautious due to bearish technicals and neutral oscillators. Key opportunities include potential rebound from oversold RSI levels near support at Rp474. Major risks involve low liquidity, regulatory uncertainty in Indonesia, and high volatility typical of small-cap cryptocurrencies.
LayerZero (ZRO) is trading at Rp15,521 with a bearish technical signal, as moving averages indicate selling pressure while oscillators are neutral. The current price sits near support at Rp15,073, with resistance at Rp16,306. Market cap is Rp5.46T with 36% of the 1M max supply in circulation. No major protocol updates or ecosystem news were noted recently.
Overall outlook is cautious due to bearish technicals and limited fundamental catalysts. Key opportunities include potential rebounds from support levels, but risks involve high volatility, low liquidity depth, and regulatory uncertainty. Investors should monitor on-chain activity for signs of network growth.
What Pluang investors did over the last 30 days
BIO Protocol enables global communities of scientists, patients, and investors to collectively fund, develop, and co-own new drugs and therapeutics through its network of Biotech Decentralized Autonomous Organizations (BioDAOs). The protocol's innovative approach addresses critical gaps in traditional scientific funding, particularly in areas such as rare diseases, longevity research, and emerging health challenges.
Read more on BIO →LayerZero is a blockchain interoperability protocol that connects various blockchains to support the development of omnichain applications and tokens. It employs immutable on-chain endpoints and a Security Stack, ensuring secure and censorship-resistant messaging across different blockchain networks.
Read more on ZRO →